Who / What
Genome editing, also known as genome engineering, is a type of genetic engineering that involves making precise changes to the DNA of a living organism. This includes inserting, deleting, modifying, or replacing DNA within a genome. Unlike earlier, more random techniques, it targets these changes to specific locations.
Background & History
The technology evolved from basic genetic engineering methods, with a key breakthrough being the development of programmable nucleases that allow for site-specific targeting. The basic mechanism involves creating double-strand breaks (DSBs) in the DNA at precise locations using engineered nucleases like FokI and Cas. These breaks are then repaired by the cell's own mechanisms, either through homology-directed recombination (HDR) or non-homologous end joining (NHEJ), enabling the desired genetic alteration.
Why Notable
Genome editing is notable for its unprecedented precision in manipulating genetic material, revolutionizing fields like medicine, agriculture, and biological research. It enables the development of potential therapies for genetic disorders and the creation of genetically modified crops with improved traits. Its ability to make targeted changes offers significant advantages over previous, less predictable methods of genetic modification.
In the News
Genome editing remains highly relevant due to ongoing advancements in tools like CRISPR-Cas9, which have made the technique more accessible and efficient. Recent developments focus on its therapeutic applications, including clinical trials for treating diseases like sickle cell anemia. Ethical and regulatory discussions concerning its use, especially in human germline editing, continue to be a major point of public and scientific debate.